Evidence map›Paper›PMID 41575515›Full record

ArticleSkeletal radiology2026

Blastic plasmacytoid dendritic cell neoplasm: dermal thickening with T2-dark band as an early imaging clue.

Shingo Omata, Hiroki Kato, Takuya Seko, Masaya Kawaguchi, Yuto Kaneda, Nobuhiro Kanemura, Yusuke Kito, Masayuki Matsuo

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shingo OmataDepartment of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan. omata.shingo.t6@f.gifu-u.ac.jp.ORCID http://orcid.org/0009-0006-8883-9434
Hiroki KatoDepartment of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Takuya SekoDepartment of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Masaya KawaguchiDepartment of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Yuto KanedaDepartment of Hematology and Infectious Disease, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Nobuhiro KanemuraDepartment of Hematology and Infectious Disease, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Yusuke KitoDepartment of Pathology and Translational Research, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Masayuki MatsuoDepartment of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive hematologic malignancy that commonly involves the skin and can rapidly disseminate. We report the case of a 58-year-old man presenting with a rapidly enlarging reddish nodule over the right scapular region, which grew from 9 to 20 cm within 1 month. Chest magnetic resonance imaging revealed marked dermal thickening with a band-like low signal on T2-weighted images ("T2-dark band"). The T2-dark dermal layer was interposed between the tumor exhibiting restricted diffusion-superficial components bulging outward and invasive subcutaneous components (the "Hamburger Sign").

Indexed as

Blastic Plasmacytoid Dendritic Cell NeoplasmMagnetic Resonance ImagingSkin NeoplasmsDendritic CellsDiagnosis, DifferentialFluorodeoxyglucose F18HumansImmunohistochemistryMaleMiddle AgedPositron Emission Tomography Computed TomographyRadiopharmaceuticalsScapulaFluorodeoxyglucose F18RadiopharmaceuticalsBlastic plasmacytoid dendritic cell neoplasm (BPDCN)Magnetic resonance imagingPositron-emission tomography

Identifiers

PMID41575515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.